Industry Statistics
- Companies: 98
- Median P/E: 26.4 (vs. sector 26.6)
- Average ROE: -6.1% (vs. sector 7.0%)
- Average debt/equity: 0.54 (vs. sector 0.80)
- Average dividend yield: 0.0% (vs. sector 0.5%)
- Average net margin: -12.1% (vs. sector -0.2%)
- Total market cap: $1.07T
Cheapest by P/E
- Aurinia Pharmaceuticals Inc. (AUPH) — P/E 6.9
- PTC Therapeutics, Inc. (PTCT) — P/E 8.9
- Acadia Pharmaceuticals Inc. (ACAD) — P/E 8.9
- Harmony Biosciences Holdings, Inc. (HRMY) — P/E 12.7
- ADMA Biologics, Inc. (ADMA) — P/E 14.0
Top Dividend Payers
Top Companies by Market Cap
- Vertex Pharmaceuticals Incorporated (VRTX) — $128.1B · P/E 29.4
- Regeneron Pharmaceuticals, Inc. (REGN) — $75.7B · P/E 17.6
- Moderna, Inc. (MRNA) — $75.4B
- argenx SE (ARGX) — $57.2B · P/E 33.5
- Revolution Medicines, Inc. (RVMD) — $43.9B
- BeOne Medicines AG (ONC) — $37.9B · P/E 26.3
- Alnylam Pharmaceuticals, Inc. (ALNY) — $29.4B · P/E 36.0
- Roivant Sciences Ltd. (ROIV) — $25.8B
- Insmed Incorporated (INSM) — $24.7B
- BioNTech SE (BNTX) — $24.7B
- Incyte Corporation (INCY) — $23.4B · P/E 14.7
- Genmab A/S (GMAB) — $21.9B · P/E 26.5
- United Therapeutics Corporation (UTHR) — $20.4B · P/E 17.9
- Exelixis, Inc. (EXEL) — $14.9B · P/E 17.7
- Jazz Pharmaceuticals plc (JAZZ) — $14.9B · P/E 15.5
- Neurocrine Biosciences, Inc. (NBIX) — $14.3B · P/E 20.3
- Ascendis Pharma A/S (ASND) — $14.2B · P/E 16.8
- Summit Therapeutics Inc. (SMMT) — $13.4B
- BridgeBio Pharma, Inc. (BBIO) — $12.9B
- Halozyme Therapeutics, Inc. (HALO) — $12.7B · P/E 31.2
- Madrigal Pharmaceuticals, Inc. (MDGL) — $11.8B
- Twist Bioscience Corporation (TWST) — $11.7B
- 10x Genomics, Inc. (TXG) — $11.4B
- Bio-Techne Corporation (TECH) — $11.3B · P/E 62.4
- BioMarin Pharmaceutical Inc. (BMRN) — $11.1B · P/E 150.5
Related industries
- Drug Manufacturers - General · 16 · $4.12T
- Medical - Diagnostics & Research · 23 · $839.2B
- Medical - Devices · 27 · $712.3B
- Medical - Healthcare Plans · 8 · $691.4B
- Medical - Instruments & Supplies · 19 · $377.6B
- Drug Manufacturers - Specialty & Generic · 14 · $242.3B
- Medical - Distribution · 4 · $228.9B
- Medical - Care Facilities · 20 · $219.8B
- Medical - Healthcare Information Services · 8 · $57.4B
- Medical - Specialties · 2 · $51.4B
- Medical - Pharmaceuticals · 5 · $48.5B
Frequently Asked Questions
How many publicly-traded companies are in the Biotechnology industry?
The Biotechnology industry has 98 publicly-listed companies in the US and Canadian markets tracked by Kaplio, with a combined market capitalization of $1.07T.
What is the median P/E ratio of Biotechnology stocks?
The Biotechnology companies above $2 billion with consistent data trade at a median P/E of 26.4. For comparison, the median of the Healthcare sector is 26.6.
What are the largest companies in the Biotechnology industry?
By market capitalization, the largest Biotechnology companies tracked by Kaplio are Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals, Inc., Moderna, Inc.. The full ranking of the top 25 companies by market cap is available above.
Which Biotechnology stocks have the highest dividend yield?
Top dividend payers in Biotechnology include Regeneron Pharmaceuticals, Inc., Bio-Techne Corporation, with an industry-average dividend yield of 0.0%.
How profitable are Biotechnology companies?
Companies in the Biotechnology industry average a net profit margin of -12.1% and a return on equity (ROE) of -6.1%, based on 98 companies tracked. Average debt-to-equity ratio is 0.54.